Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iodine I-131 gamma globulin is a radiopharmaceutical consisting of human gamma globulin labeled with the radioisotope iodine-131. It is primarily used as a diagnostic tracer in clinical research to evaluate the metabolism, distribution, and catabolic rates of immune proteins in various disease states. By measuring the radioactivity in blood and urine over time, researchers can calculate the catabolic half-life and distribution space of the protein. Historically, it has been employed to study protein turnover in conditions such as amyloidosis, rheumatoid arthritis, and the nephrotic syndrome, providing insights into how these diseases alter the body's handling of gamma globulins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iodine I-131 gamma globulin.